BCOR 14.02 Blucora Inc $BCOR Hit a 52 week low of 13.40

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 11:08 AM

BCOR 14.02 Blucora Inc $BCOR Hit a 52 week low of 13.40 Closing the day 10:45 at 14.02 +0.41 +3.01% With a day low of 13.40 and a total volume of 211,677.

BCOR Recent Posts: http://investorshangout.com/Blucora-Inc-BCOR-54467/

BCOR Blucora Inc Recent Headline News

Activist Fund Targets Ebix to Boost Board Oversight and Unlock Value
at The Street - Mon Nov 17, 5:10AM CST
Barington Capital sent Ebix a letter to call for improved board oversight. Could this be the catalyst the market needs to realize Ebix's value?
SAFT: 60.10 (+0.15), RF: 10.02 (-0.05), CSGS: 25.33 (+0.17), AON: 90.55 (+0.16), EPIQ: 15.81 (+0.12), LRN: 12.20 (+0.10), DRI: 55.99 (+0.38), DDS: 113.63 (+2.87), LOGM: 50.08 (-0.06), WSH: 42.39 (-0.07), EBIX: 16.02 (+0.07), TRAK: 45.55 (+0.51), SCOR: 43.10 (+0.13), BCOR: 14.00 (+0.39), NAVG: 71.31 (+1.45), UVE: 18.72 (+0.49)

Blucora's (BCOR) CEO William Ruckelshaus on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 7:01PM CST

BCOR: 14.00 (+0.39)

Blucora reports 3Q loss
Automated Insights - Wed Nov 05, 6:24PM CST
BELLEVUE, Wash. (AP) _ Blucora Inc. (BCOR) on Wednesday reported a loss of $2.2 million in its third quarter.
BCOR: 14.00 (+0.39)

Blucora (BCOR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:55PM CST

BCOR: 14.00 (+0.39)

Blucora beats by $0.06, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:34PM CST

BCOR: 14.00 (+0.39)

Blucora Reports Third Quarter Results
Marketwired - Wed Nov 05, 3:25PM CST
Blucora, Inc. (NASDAQ: BCOR) today announced financial results for the third quarter ended September 30, 2014.
BCOR: 14.00 (+0.39)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST

CXO: 118.63 (+3.47), CODI: 16.63 (-0.02), EXXI: 7.11 (+0.30), JCOM: 55.60 (-0.39), ATSG: 7.95 (+0.07), GPOR: 53.39 (+1.87), ENS: 60.41 (+0.11), ECYT: 6.35 (+0.05), ALNY: 88.93 (-0.64), KGC: 2.78 (+0.04), GSM: 17.11 (+0.08), BKD: 35.06 (+0.40), DK: 31.68 (-0.08), AR: 53.25 (+0.95), IL: 10.54 (+0.07), DVR: 0.14 (-0.08), IO: 2.73 (+0.13), DEPO: 15.20 (+0.01), ETE: 62.85 (-1.05), AVG: 19.27 (+0.04), CSOD: 30.34 (+0.50), GNW: 9.25 (+0.12), ECOL: 39.23 (-0.03), BWC: 30.05 (+0.01), CPE: 6.20 (+0.31), FNV: 53.58 (+0.39), CTL: 40.53 (-0.59), ASH: 112.56 (-0.28), ENSG: 38.94 (+0.34), CLR: 54.71 (+1.85), ACAS: 14.90 (+0.03), G: 17.80 (+0.08), BREW: 13.73 (+0.02), AWK: 52.30 (-0.13), CVG: 20.74 (+0.09), AREX: 10.97 (+0.35), HTCH: 3.50 (+0.04), ETP: 67.45 (-0.30), ABTL: 10.79 (+0.21), FMI: 23.91 (-0.23), DPM: 52.93 (+0.67), BCOR: 14.00 (+0.39), CDE: 4.36 (+0.11), DRYS: 1.43 (unch), KW: 25.60 (+0.04), BALT: 3.39 (+0.16), ATO: 52.83 (-0.31), EXAR: 8.62 (+0.01), ACLS: 2.13 (-0.02), INWK: 7.36 (+0.08), ALSK: 1.30 (-0.01), CF: 272.89 (+0.86), EFC: 21.79 (-0.01), BIOS: 5.86 (+0.06), DYN: 33.83 (+0.25), DATA: 79.99 (-0.24), ANDE: 56.55 (+0.85), HOLX: 26.23 (-0.06), CBS: 53.57 (+0.23)

Motiwala Capital Q3 Review Letter
Adib Motiwala - at Seeking Alpha - Thu Oct 30, 5:35AM CDT

HES: 83.18 (+0.81), CTCM: 5.86 (-0.06), QCOM: 70.26 (-0.21), NADL: 3.25 (+0.09), BCOR: 14.00 (+0.39), VOD: 35.62 (-0.07), ORCL: 40.96 (+0.04), OUTR: 64.08 (+1.34)

Blucora to Announce Third Quarter Financial Results on November 5, 2014
Marketwired - Wed Oct 29, 5:15PM CDT
Blucora, Inc. (NASDAQ: BCOR) will announce its third quarter 2014 financial results on Wednesday, November 5, 2014, after market close.
BCOR: 14.00 (+0.39)

TaxACT Empowers Small Business Owners to Confidently Take Charge of Their Taxes
Marketwired - Thu Oct 16, 9:25AM CDT
TaxACT(R), the critically acclaimed leader of affordable tax preparation solutions, has released its digital and download products for 2014 small business tax returns.
BCOR: 14.00 (+0.39)

TaxACT 2014 Gives Professional Tax Preparers a Running Start to Tax Season
Marketwire - Tue Oct 07, 9:43AM CDT
TaxACT(R), the value leader of professional tax preparation and filing solutions, has released its 2014 federal software for 1040, 1065, 1120S, 1120 and 1041 returns. All TaxACT 2014 Preparer's Editions offer tools for organization, year-end tax planning and return preparation.
BCOR: 14.00 (+0.39)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
CPL: 14.99 (+0.43), EBIX: 16.02 (+0.07), AVH: 13.48 (+0.19), BCOR: 14.00 (+0.39), BLMN: 22.35 (+0.53)

Blucora Announces Appointment of Mark Finkelstein as Chief Legal and Administrative Officer
Marketwire - Thu Oct 02, 7:52PM CDT
Blucora, Inc. (NASDAQ: BCOR) today announced the appointment of Mark Finkelstein as Chief Legal and Administrative Officer, effective September 30. Mr. Finkelstein will oversee the Company's legal, compliance, and human resources departments and serve as an advisor on legal and corporate strategy matters. The Company's General Counsel & Secretary and its Vice President of Human Resources will report directly to him.
BCOR: 14.00 (+0.39)

TaxACT Launches Its Free Tax Planning Solutions for 2014 Tax Returns
Marketwire - Thu Oct 02, 10:17AM CDT
TaxACT(R), the critically acclaimed leader of digital and download tax preparation solutions, has released tax year 2014 federal solutions. With all e-fileable forms, TaxACT is the only year-round DIY tax planning and preparation solution that's free for all consumers.
BCOR: 14.00 (+0.39)

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
ACAS: 14.90 (+0.03), CHTR: 160.00 (+1.37), CPRT: 34.23 (+0.12), CRZO: 51.21 (+1.19), BCOR: 14.00 (+0.39)

Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
BWC: 30.05 (+0.01), ACAS: 14.90 (+0.03), AFOP: 12.73 (+0.39), BCOR: 14.00 (+0.39), BLMN: 22.35 (+0.53)

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
BDE: 8.47 (-0.09), ALOG: 71.05 (-0.56), ASEI: 49.35 (+0.85), BCOR: 14.00 (+0.39), AIR: 25.51 (-0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...